experimental vaccine

Phase 3Vaccine

Sinovac Biotech Co., Ltd

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Epidemic MeningitisRecruiting

Epidemic MeningitisPhase 3

Recruiting

Timeline

Expected Milestones

Q4 2026

Phase 3Active, not recruiting

Epidemic Meningitis

NCT07505888

Q1 2027

Phase 3Recruiting

Epidemic Meningitis

NCT07505836

Q1 2028

Phase 3Recruiting

Epidemic Meningitis

NCT07505823

Phase 3Recruiting

Epidemic Meningitis

NCT07505810

Clinical

Trials by Indication[1]

Epidemic Meningitis4 trials

A Randomized, Double-Blind, Active Comparator-Controlled Phase Ⅲ Trial to Evaluate the Immunogenicity and Safety of the Group ACYW135 Meningococcal Conjugate Vaccine in Population Aged 6 to 11 Months

Recruiting· Sinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd·Phase 3·NCT07505823·1,040 enrolled

A Randomized, Double-Blind, Active Comparator-Controlled Phase Ⅲ Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine in Population Aged 2-6 Years

Active, not recruiting· Sinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd·Phase 3·NCT07505888·660 enrolled

Recruiting· Sinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd·Phase 3·NCT07505810·880 enrolled

Show 1 more trial

Recruiting· Sinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd·Phase 3·NCT07505836·1,040 enrolled

Immunogenicity3 trials

Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants

Completed· Sinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd·Phase 3·NCT05386810·1,572 enrolled

Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese

Completed·JJiangsu Province Centers for Disease Control and Prevention·Phase 3·NCT03714737·1,950 enrolled

To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

Completed·HHualan Biological Bacterin Co. Ltd.·Phase 3·NCT06177249·1,956 enrolled

Enterovirus 71 Inactivated Vaccine1 trial

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

Unknown status· Sinovac Biotech Co., Ltd logo

Sinovac Biotech Co., Ltd·Phase 4·NCT05397587·474 enrolled

Hepatitis B1 trial

The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates

Completed·JJiangsu Province Centers for Disease Control and Prevention·Phase 3·NCT01183611·1,740 enrolled

Sources

References

[1]
ClinicalTrials.gov — 9 trial records for experimental vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — experimental vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for experimental vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sinovac Biotech Co., Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 3[1]
Company: Sinovac Biotech Co., Ltd

experimental vaccine

Status by Indication[3][1]

Expected Milestones

Q4 2026

Q1 2027

Q1 2028

Trials by Indication[1]

Epidemic Meningitis4 trials

Immunogenicity3 trials

Enterovirus 71 Inactivated Vaccine1 trial

Hepatitis B1 trial

References

Drug Info

Quick Facts

Related News